Radiation Retinopathy: Clinical Trials

5 trials for Radiation Retinopathy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 unknown. 5 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 15Completed 3, Unknown 2

Follow Radiation Retinopathy: new trials by email Literature Review of Radiation Retinopathy trials Research Report on Radiation Retinopathy

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase I Study of Episcleral Celecoxib for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole
Episcleral Celecoxib - Macula Edema, Radiation Retinopathy
Phase 1UnknownTargeted Therapy Technologies, LLC32021-03-052023-11-24
Episcleral Dexamethasone for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole
Episcleral Dexamethasone - Macular Edema, Radiation Retinopathy
Phase 1UnknownTargeted Therapy Technologies, LLC22019-09-012023-11-24
Intravitreal Aflibercept Injection for Radiation Retinopathy
Aflibercept every 2 months, Aflibercept monthly - Radiation Retinopathy, Macular Edema
Phase 1CompletedWashington University School of Medicine92012-11-012019-04-25
High Dose Intravitreal Ranibizumab for Recalcitrant Radiation Retinopathy
ranibizumab 2.0 mg - Radiation Retinopathy
Phase 1CompletedThe New York Eye Cancer Center102011-05-012014-10-02
Effect of Intravitreal Ranibizumab on Radiation Retinopathy Following Plaque Brachytherapy for Choroidal Melanoma
Ranibizumab, ranibizumab - Radiation Retinopathy, Choroidal Melanoma
Phase 1CompletedThe New York Eye Cancer Center102008-10-012012-04-26

Narrower conditions

Retinal Diseases (3)  ·  Epiretinal Membrane (2)  ·  Macular Edema (2)  ·  Retinal Vein Occlusion (2)  ·  Uveitis, Intermediate (2)  ·  Melanoma (1)  ·  Uveal Melanoma (1)

Broader conditions

Eye Diseases (5)  ·  Uveal Diseases (3)  ·  Cardiovascular Diseases (2)  ·  Embolism and Thrombosis (2)  ·  Macular Degeneration (2)  ·  Retinal Degeneration (2)  ·  Retinal Diseases (2)  ·  Thrombosis (2)  ·  Uveitis (2)  ·  Vascular Diseases (2)  ·  Venous Thrombosis (2)  ·  Eye Neoplasms (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms by Site (1)

Interventions

Ranibizumab (2)  ·  aflibercept (1)

Sponsors

Targeted Therapy Technologies, LLC (2)  ·  The New York Eye Cancer Center (2)  ·  Washington University School of Medicine (1)

Countries

United States (5)

Top investigators

Paul T Finger, MD (2)  ·  Theodore Leng, MD (2)  ·  Prabakar K Rao, MD (1)

Results publications

PMID 20142553, PMID 36912792